I will be presenting data on an animal model of Multiple Sclerosis (MS) progression, how we have used this model to better understand disease progression and to understand how MS treatments impact this process. By going back and forth between the animal model and MS tissues, we have learned about what can trigger so-called “compartmentalized inflammation” in MS, and have unveiled a potential fluid biomarker that reflects this inflammation.